U.S. Markets open in 8 hrs, 37 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,602.50 | 135.16 | 1.18% |
| NASDAQ | 2,303.96 | 24.43 | 1.07% |
| S&P 500 | 1,277.00 | 17.00 | 1.35% |
| Day Low 09:34 AM EDT | 51.08 | |
|---|---|---|
| Day High 01:59 PM EDT | 52.10 |
|
| Range | 1.02 | |
| Volume | 1.84 M | |
| 30-Day Avg. Vol. | 2.42 M |
|
| Difference | -24.22% | |
| Market Cap. | 15.86 B | |
| Change | 106.74 M | |
| Shares Out. | 304.99 M | |
| Percent Traded | 0.60% | |
| Revenue | 3.93 B | |
| Earnings | 498.3 M | |
| EPS (TTM) | 1.84 |
| 52-Wk Low 7/8/08 | 50.21 | |
|---|---|---|
| 52-Wk High 1/14/08 | 70.40 |
|
| Range | 20.19 | |
| Prev. Close 7/21/08 | 51.68 | |
| Today's Open | 51.42 | |
| Change | -0.50% | |
| Dividend (TTM) | 0.20 | |
| Div. Yield (TTM) | 0.38% |
|
| Beta | 1.0902 | |
| P/E Ratio (TTM) | 28.43 | |
| P/E Ratio (Fwd.) | 19.00 |
Don't let the name fool you, Allergan can't help you with that runny nose. Instead, the company is a leading maker of eye care and skin care products; it also produces best-selling pharmaceutical Botox. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.576 12/31/07 | 0.60 12/31/07 |
0.024
Beat
|
| Last Quarter | 0.519 3/31/08 | 0.53 3/31/08 |
0.011
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 1.08 B | 3.94 B |
| Gross Profit | 859.50 M | 3.14 B |
| Operating Income | 194.40 M | 841.60 M |
| Net Income | 111.40 M | 498.30 M |
Real-Time Quote
